Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by Busyzzindahouseon Dec 14, 2016 10:34am

40 Views

Post# 25597862

RE:RE:RE:NF

Mecheng.....could also be carmen selling hisn15 million shares....i reckon we will linger here until his shares are all sold.

mecheng wrote: someone dropped 200k then 300k shares. interesting.
i guess they had it with waiting? too premature imo. It's the same model as VP so it should be in the 20's range. The drop is definitely not warranted.

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages